Cumberland Pharmaceuticals (CPIX) Other Non-Current Liabilities (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 17 years of Other Non-Current Liabilities data on file, last reported at $5.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 6.44% year-over-year to $5.6 million; the trailing twelve-month figure through Mar 2026 stood at $5.6 million (down 6.44% YoY), and the FY2025 full-year result was $5.8 million, down 7.58% from the prior year.
• Other Non-Current Liabilities fell to $5.6 million in Q1 2026, from $5.8 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $11.3 million in Q1 2022 to a low of $5.6 million in Q1 2026.
• A 5-year average of $7.1 million and a median of $6.5 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities jumped 44.56% in 2022 and slumped 37.38% in 2023, its largest moves.
• Tracing CPIX's Other Non-Current Liabilities over 5 years: stood at $7.6 million in 2022, then slipped by 14.92% to $6.5 million in 2023, then decreased by 2.38% to $6.3 million in 2024, then dropped by 7.58% to $5.8 million in 2025, then declined by 3.48% to $5.6 million in 2026.
• Business Quant data shows CPIX's Other Non-Current Liabilities at $5.6 million in Q1 2026, $5.8 million in Q4 2025, and $6.0 million in Q3 2025.